X4 Pharmaceuticals, Inc. (XFOR) CEO Paula Ragan on Q1 2022 Results - Earnings Call Transcript [Seeking Alpha]
X4 Pharmaceuticals, Inc. (XFOR)
Last x4 pharmaceuticals, inc. earnings: 3/12 07:30 am
Check Earnings Report
Company Research
Source: Seeking Alpha
X4 Pharmaceuticals, Inc. (NASDAQ:XFORCompany ParticipantsGlenn Schulman - Vice President, Investor Relations and Corporate CommunicationsPaula Ragan - President and Chief Executive OfficerAdam Mostafa - Chief Financial OfficerDiego Cadavid - Chief Medical OfficerArthur Taveras - Chief Scientific OfficerConference Call ParticipantsMarc Frahm - Cowen & CompanyWilliam Wood - B. Riley SecuritiesTrevor Howard - OppenheimerZegbeh Jallah - ROTH Capital PartnersOperatorGreetings and welcome to X4 Pharmaceuticals First Quarter 2022 Financial and Operating Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. As a reminder, this conference call is being recorded.It is now my pleasure to introduce your host Dr. Glenn Schulman, Head of Investor Relations. Please begin.Thank you, operator and good morning everyone. Presenting on today's call will be X4's Chief Executive Officer, Dr. Paula Ragan and the
Show less
Read more
Impact Snapshot
Event Time:
XFOR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
XFOR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
XFOR alerts
High impacting X4 Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
XFOR
News
- X4 Pharmaceuticals: PDUFA Excitement Ahead [Seeking Alpha]Seeking Alpha
- X4 Pharmaceuticals, Inc.'s (NASDAQ:XFOR) market cap decline of US$42m may not have as much of an impact on institutional owners after a year of 7.0% returns [Yahoo! Finance]Yahoo! Finance
- X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- X4 Pharmaceuticals to Participate in Upcoming April Investor ConferencesGlobeNewswire
- X4 Pharmaceuticals, Inc. (NASDAQ: XFOR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.MarketBeat
XFOR
Earnings
- 3/21/24 - Beat
XFOR
Analyst Actions
- 3/22/24 - HC Wainwright
XFOR
Sec Filings
- 4/5/24 - Form 8-K
- 4/1/24 - Form 8-K
- 3/21/24 - Form 10-K
- XFOR's page on the SEC website